High-dose interleukin-2 immunotherapy is
β
JOHN P. BRUSKY; FAWEZ GAILANI; APURBA PATHAK; HATEL PATEL; SHERIF ABOSEIF
π
Article
π
2006
π
John Wiley and Sons
π
English
β 59 KB